Effects of Virtual Reality and Helfer Skin Tap During Vaccination
Launched by MEHMET AKIF ERSOY UNIVERSITY · Mar 19, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how two different methods, Virtual Reality and Helfer Skin Tap, can help reduce pain, fear, and anxiety in children receiving the Tetanus-Diphtheria vaccine. The goal is to see which method makes the vaccination experience more comfortable and satisfying for children aged 13 years. In this study, 138 children will be randomly placed into one of three groups: one using Virtual Reality, one receiving the Helfer Skin Tap technique, and a control group.
To be eligible for this trial, participants must be 13 years old and able to communicate. However, children with certain medical conditions, those taking specific medications within the past day, or those who refuse to try the methods will not be included. Throughout the trial, participants will be monitored for their feelings of anxiety and pain using simple questionnaires. This study aims to make vaccinations less stressful for children and improve their overall experience.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 13 years
- • being conscious (with the ability to communicate)
- Exclusion Criteria:
- • having a physical and psychological condition
- • taking any analgesics, sedatives, or anticonvulsants in the past 24 hours
- • having chronic or life-threatening disease
- • refusing the virtual reality or helfer skin tap technique intervention during vaccine injection.
About Mehmet Akif Ersoy University
Mehmet Akif Ersoy University is a distinguished educational and research institution dedicated to advancing healthcare through innovative clinical trials. With a commitment to scientific excellence and ethical standards, the university focuses on a diverse array of medical research initiatives aimed at improving patient outcomes and enhancing the understanding of various health conditions. Through collaboration with healthcare professionals and researchers, Mehmet Akif Ersoy University fosters an environment that encourages rigorous inquiry and the translation of research findings into practical applications, ultimately contributing to the betterment of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Burdur, , Turkey
Patients applied
Trial Officials
Nihal TASKIRAN
Study Chair
Aydin Adnan Menderes University
Seyma KISLALI TAS
Study Chair
Manisa Soma Family Health Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported